Novel function of a mitochondria phosphatase in cardiac development
Novel function of a mitochondria phosphatase in cardiac development
批准号:
10436945
负责人:
Ju Chen
金额:
$54.57万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-01 至 2025-06-30
关键词:
AddressAffectApoptosisAttenuatedBioinformaticsBiological ProcessCardiacCardiac MyocytesCardiac developmentCell Cycle ArrestCellsCrista ampullarisDNADataDefectDevelopmentEmbryoFibroblastsGenesGenetic TranscriptionHeartHeart AbnormalitiesHomeostasisInner mitochondrial membraneKnock-outKnockout MiceLoxP-flanked alleleMedialMitochondriaMitochondrial ProteinsModelingMolecularMorphogenesisMorphologyMusMutationMyocardiumNuclearOxygen ConsumptionPathway interactionsPhenotypePhosphatidylinositol PhosphatesPhospholipidsPhosphoric Monoester HydrolasesPhysiologicalPlayProcessProtein Tyrosine PhosphataseRespirationRoleSignal TransductionSmooth MuscleSpecificityStressSuccinate DehydrogenaseZebrafishactivating transcription factor 4biological adaptation to stresscalcificationcardiogenesiscongenital heart disorderembryonic stem cellendoplasmic reticulum stressheart functionimplantationin vivoinhibitorinsightlipidomicsloss of functionmitochondrial dysfunctionmouse modelnovelphosphatidylglycerophosphatephosphoproteomicsresponsesenescencetranscriptome sequencing
中文摘要
项目总结
线粒体是心肌细胞分化和心脏形态发生所必需的。基因突变
编码线粒体蛋白的基因经常会导致先天性心脏病,这突显了
阐明心脏发育过程中线粒体动态平衡的关键分子途径(S)。蛋白质酪氨酸
定位于线粒体1的磷酸酶(PTPMT1)是一种双特异性线粒体磷酸酶
由核DNA编码。PTPMT1仅定位于线粒体,锚定在内部
线粒体膜。PTPMT1在不同发育阶段的细胞质雄性不育中均有表达。至
为了确定PTPMT1在CMS中的作用,我们产生了Ptpmt1结构性CM特异性基因敲除(CKO)小鼠
模特。我们的初步数据显示,Ptpmt1 CKO小鼠表现出胚胎致死性。Ptpmt1 CKO小鼠
表现为致密带心肌变薄,心肌细胞增殖减少。我们还显著地观察到
Ptpmt1 CKO心脏线粒体呼吸频率降低和线粒体形态异常,
证明PTPMT1在CMS的发育和维持正常线粒体中起关键作用
动态平衡。我们还检查了之前描述的Ptpmt1CKO心脏中的PTPMT1底物与
对照,但没有发现证据支持它们是CMS中PTPMT1的直接底物。为了获得更多
为了深入了解PTPMT1缺失对通路的影响,我们对Ptpmt1 CKO心脏进行了RNA-SEQ分析。
生物信息学分析表明,PTPMT1的缺失显著激活了激活的转录因子
4(ATF4)途径。ATF4调控一系列允许细胞存活的适应性基因的表达
线粒体应激期。然而,在持续的应激条件下,ATF4促进细胞-
细胞周期停滞、细胞凋亡和衰老。值得注意的是,ATF4在全球ATF4单倍体缺陷和
平滑肌特异性ATF4基因敲除小鼠减轻内质网应激,减轻内侧动脉和动脉粥样硬化
钙化,突出了通过偏爱缓解压力的适应效果而不是
通过调节ATF4的激活而产生的不适应效应。上述证据使我们得出这样的假设:
PTPMT1通过调节特定底物在心脏发育中发挥重要作用。
在Ptpmt1基因敲除的CMS中,线粒体应激激活的ATF4的部分丢失可能会改善,
但ATF4的完全缺失可能会加剧Ptpmt1 CKO表型。据此,我们的具体目标是:1.
PTPMT1在心肌线粒体动态平衡和心脏发育与功能中的作用
分析Ptpmt1 CKO小鼠,并通过执行以下步骤鉴定CMS中PTPMT1的内源性底物
无偏见的脂类组学和磷蛋白质组学分析;以及2.确定部分或
CMS中ATF4基因完全缺失对CKO小鼠Ptpmt1表型的影响
基因敲除/ATF4杂合(HcKO)小鼠和CM特异性Ptpmt1/ATF4双基因敲除(DcKO)小鼠。
英文摘要
PROJECT SUMMARY
Mitochondria are essential for cardiomyocyte (CM) differentiation and cardiac morphogenesis. Mutations in
genes encoding mitochondrial proteins frequently result in congenital heart disease, highlighting the need to
elucidate key molecular pathway(s) in mitochondrial homeostasis during heart development. Protein Tyrosine
Phosphatase localized to the Mitochondrion 1 (PTPMT1) is a dual-specificity mitochondrial phosphatase
encoded by nuclear DNA. PTPMT1 is exclusively localized to mitochondria, being anchored to the inner
mitochondrial membrane. PTPMT1 is expressed in CMs throughout several developmental stages. To
determine the role of PTPMT1 in CMs, we generated a Ptpmt1 constitutive CM-specific knockout (cKO) mouse
model. Our preliminary data revealed that Ptpmt1 cKO mice display embryonic lethality. Ptpmt1 cKO mice
displayed thinner compact zone myocardium, with decreased CM proliferation. We also observed significantly
decreased mitochondrial respiration rate and abnormal mitochondrial morphology in Ptpmt1 cKO hearts,
demonstrating that PTPMT1 plays a critical role in developing CMs and in maintaining normal mitochondrial
homeostasis. We also examined previously described PTPMT1 substrates in Ptpmt1 cKO hearts relative to
controls, but could find no evidence to support them being direct substrates of PTPMT1 in CMs. To gain further
insight into pathways affected by loss of PTPMT1, we performed RNA-seq analysis of Ptpmt1 cKO hearts.
Bioinformatics analysis revealed that loss of PTPMT1 significantly activated the Activating Transcription Factor
4 (ATF4) pathway. ATF4 controls expression of a wide range of adaptive genes that allow cells to survive
periods of mitochondrial stress. However, under persistent stress conditions, ATF4 promotes induction of cell-
cycle arrest, apoptosis and senescence. Notably, reduced expression of ATF4 in global Atf4-haplodeficient and
smooth muscle-specific Atf4 knockout mice attenuates ER stress and reduces medial and atherosclerotic
calcification, highlighting new opportunities afforded by favoring a stress-relief adaptive effect over a
maladaptive effect by modulating ATF4 activation. The foregoing evidence leads us to the hypothesis that
PTPMT1 plays an essential role in cardiac development through modulation of specific substrates, and that
partial loss of ATF4, activated in response to mitochondrial stress in Ptpmt1 knockout CMs, may ameliorate,
but complete loss of ATF4 may exacerbate, Ptpmt1 cKO phenotypes. Accordingly, our specific aims are to: 1.
Elucidate the role of PTPMT1 in CM mitochondrial homeostasis and cardiac development and function by
analyzing Ptpmt1 cKO mice, and to identify endogenous substrates of PTPMT1 in CMs by performing
unbiased lipidomics and phosphoproteomics analyses; and 2. Determine the consequences of partial or
complete loss of ATF4 in CMs on phenotypes of Ptpmt1 cKO mice by analyzing CM-specific Ptpmt1
knockout/Atf4 heterozygous (hcKO) knockout mice and CM-specific Ptpmt1/Atf4 double knockout (dcKO) mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ATF4 a Novel Regulator of Cardiac Development
-
批准号:10657081
-
项目类别:
-
资助金额:$55.3万
-
财政年份:2023
-
负责人:Ju Chen
-
依托单位:
Protein Kinase Novel 2 (PKN2) in heart
-
批准号:10322445
-
项目类别:
-
资助金额:$54.7万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
Nuclear envelope protein LEMD2 in heart
-
批准号:10278926
-
项目类别:
-
资助金额:$55.3万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
Protein Kinase Novel 2 (PKN2) in heart
-
批准号:10548141
-
项目类别:
-
资助金额:$54.24万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
Nuclear envelope protein LEMD2 in heart
-
批准号:10662287
-
项目类别:
-
资助金额:$53.9万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
Novel function of a mitochondria phosphatase in cardiac development
-
批准号:10181409
-
项目类别:
-
资助金额:$55.3万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
Novel function of a mitochondria phosphatase in cardiac development
-
批准号:10687847
-
项目类别:
-
资助金额:$53.91万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
Nuclear envelope protein LEMD2 in heart
-
批准号:10463758
-
项目类别:
-
资助金额:$54.61万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
PRDM16 in cardiac development
-
批准号:10025986
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2020
-
负责人:Ju Chen
-
依托单位:
PRDM16 in cardiac development
-
批准号:10242912
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2020
-
负责人:Ju Chen
-
依托单位:
PRDM16 in cardiac development
-
批准号:10615837
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2020
-
负责人:Ju Chen
-
依托单位:
PRDM16 in cardiac development
-
批准号:10414087
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2020
-
负责人:Ju Chen
-
依托单位:
ALPK3 in cardiac function and disease
-
批准号:10360581
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2019
-
负责人:Ju Chen
-
依托单位:
The Cardiac Role of Filamin C
-
批准号:10322727
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2019
-
负责人:Ju Chen
-
依托单位:
The role of Nexilin in cardiomyocyte and cardiomyopathy
-
批准号:9925817
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2017
-
负责人:Ju Chen
-
依托单位:
Adipocytes and cardiac remodeling
-
批准号:9010674
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2015
-
负责人:Ju Chen
-
依托单位:
Adipocytes and cardiac remodeling
-
批准号:9198055
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2015
-
负责人:Ju Chen
-
依托单位:
Luma in Cardiac Function and Disease
-
批准号:8748180
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:Ju Chen
-
依托单位:
Luma in Cardiac Function and Disease
-
批准号:8894593
-
项目类别:
-
资助金额:$38.17万
-
财政年份:2014
-
负责人:Ju Chen
-
依托单位:
Luma in Cardiac Function and Disease
-
批准号:9314615
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:Ju Chen
-
依托单位:
海外基金